Home
About
Directory
Promoted Listings
Purchase Data
Drug Pipelines
Data Licensing
Newsletter
Contact
Celltech
is defunct.
Acquired by UCB, May 2004, $2.7B
------------------
If you believe any of this information is incorrect, please
let us know
.